These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 23202505

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV).
    Ruiz-Jarabo CM, Ly C, Domingo E, de la Torre JC.
    Virology; 2003 Mar 30; 308(1):37-47. PubMed ID: 12706088
    [Abstract] [Full Text] [Related]

  • 3. Arenavirus extinction through lethal mutagenesis.
    de la Torre JC.
    Virus Res; 2005 Feb 30; 107(2):207-14. PubMed ID: 15649566
    [Abstract] [Full Text] [Related]

  • 4. Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses.
    de la Torre JC.
    Ann N Y Acad Sci; 2009 Sep 30; 1171 Suppl 1():E57-64. PubMed ID: 19751403
    [Abstract] [Full Text] [Related]

  • 5. Ribavirin can be mutagenic for arenaviruses.
    Moreno H, Gallego I, Sevilla N, de la Torre JC, Domingo E, Martín V.
    J Virol; 2011 Jul 30; 85(14):7246-55. PubMed ID: 21561907
    [Abstract] [Full Text] [Related]

  • 6. Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity.
    Miranda PO, Cubitt B, Jacob NT, Janda KD, de la Torre JC.
    ACS Infect Dis; 2018 May 11; 4(5):815-824. PubMed ID: 29405696
    [Abstract] [Full Text] [Related]

  • 7. Targeting the proteolytic processing of the viral glycoprotein precursor is a promising novel antiviral strategy against arenaviruses.
    Rojek JM, Pasqual G, Sanchez AB, Nguyen NT, de la Torre JC, Kunz S.
    J Virol; 2010 Jan 11; 84(1):573-84. PubMed ID: 19846507
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor.
    Ortiz-Riaño E, Ngo N, Devito S, Eggink D, Munger J, Shaw ML, de la Torre JC, Martínez-Sobrido L.
    J Virol; 2014 Jan 11; 88(2):878-89. PubMed ID: 24198417
    [Abstract] [Full Text] [Related]

  • 9. Counteracting quasispecies adaptability: extinction of a ribavirin-resistant virus mutant by an alternative mutagenic treatment.
    Perales C, Agudo R, Domingo E.
    PLoS One; 2009 Jan 11; 4(5):e5554. PubMed ID: 19436746
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid.
    Vázquez-Calvo Á, Martín-Acebes MA, Sáiz JC, Ngo N, Sobrino F, de la Torre JC.
    Antiviral Res; 2013 Aug 11; 99(2):172-9. PubMed ID: 23735299
    [Abstract] [Full Text] [Related]

  • 13. Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.
    Ngo N, Henthorn KS, Cisneros MI, Cubitt B, Iwasaki M, de la Torre JC, Lama J.
    J Virol; 2015 Nov 11; 89(21):10924-33. PubMed ID: 26292327
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.
    Cheng BY, Ortiz-Riaño E, de la Torre JC, Martínez-Sobrido L.
    J Virol; 2015 Jul 11; 89(14):7373-84. PubMed ID: 25972555
    [Abstract] [Full Text] [Related]

  • 16. Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections.
    Perales C, Agudo R, Tejero H, Manrubia SC, Domingo E.
    PLoS Pathog; 2009 Nov 11; 5(11):e1000658. PubMed ID: 19911056
    [Abstract] [Full Text] [Related]

  • 17. Novel antiviral strategies to combat human Arenavirus infections.
    Kunz S, de la Torre JC.
    Curr Mol Med; 2005 Dec 11; 5(8):735-51. PubMed ID: 16375709
    [Abstract] [Full Text] [Related]

  • 18. No evidence of selection for mutational robustness during lethal mutagenesis of lymphocytic choriomeningitis virus.
    Martín V, Grande-Pérez A, Domingo E.
    Virology; 2008 Aug 15; 378(1):185-92. PubMed ID: 18572218
    [Abstract] [Full Text] [Related]

  • 19. Development of live-attenuated arenavirus vaccines based on codon deoptimization.
    Cheng BY, Ortiz-Riaño E, Nogales A, de la Torre JC, Martínez-Sobrido L.
    J Virol; 2015 Apr 15; 89(7):3523-33. PubMed ID: 25589652
    [Abstract] [Full Text] [Related]

  • 20. The High Degree of Sequence Plasticity of the Arenavirus Noncoding Intergenic Region (IGR) Enables the Use of a Nonviral Universal Synthetic IGR To Attenuate Arenaviruses.
    Iwasaki M, Cubitt B, Sullivan BM, de la Torre JC.
    J Virol; 2016 Jan 06; 90(6):3187-97. PubMed ID: 26739049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.